NASDAQ:OLMA | Profit Breakdown | Olema Pharmaceuticals, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$67.18M-$63.2M
2026-03-31-$57.99M-$53.09M
2025-12-31-$50.08M-$46.06M
2025-09-30-$45.88M-$42.22M
2025-06-30-$47.86M-$43.78M
2025-03-31-$34.87M-$30.39M
2024-12-31-$36.77M-$33.57M
2024-09-30-$37.62M-$34.56M
2024-06-30-$33.53M-$30.38M
2024-03-31-$34.34M-$30.97M
2023-12-31-$30.42M-$26.77M
2023-09-30-$23.34M-$21.5M
2023-06-30-$21.6M-$20.1M
2023-03-31-$29.6M-$28.29M
2022-12-31-$27.22M-$26.18M
2022-09-30-$23.22M-$22.72M
2022-06-30-$33.29M-$32.86M
2022-03-31-$23.25M-$23.03M
2021-12-31-$21.76M-$21.64M
2021-09-30-$17.76M-$17.71M
2021-06-30-$16.52M-$16.41M
2021-03-31-$15.45M-$15.34M
2020-12-31-$10.13M-$10.13M
2020-09-30-$7.87M-$7.84M
2020-06-30-$2.49M-$2.45M
2020-03-31-$1.04M-$1.69M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$178.7M-$162.45M-$162.45M
2024-12-31-$142.26M-$129.47M-$129.47M
2023-12-31-$104.96M-$96.66M
2022-12-31-$106.99M-$104.79M
2021-12-31-$71.49M-$71.1M
2020-12-31-$21.53M-$22.12M
2019-12-31-$4.32M-$4.32M